|
|
|
By Aurea M. Flores, Ph.D. | Consultant Aurea Flores, Ph.D., offers specific advice for evaluating whether a new technology is embraced by site staff and fulfilling its purpose for the sponsor. |
|
|
|
| Measuring The True Patient Experience | Article | Castor | Utilizing the insights covered in this article can inform the design and implementation of cancer trials, ultimately contributing to improved patient care and treatment outcomes. |
|
|
| Accelerating Site Activation | Article | By Rosemary Shirey, IQVIA Technologies | As protocols and studies become more complex, using technology to offer sites in-depth expertise and guidance is more important than ever to launch studies on time. |
|
|
|
| Driving Successful Obesity Drug Development With GLP-1 Agonists | Article | By Antonina Wasuna, Ph.D., Manuela Bossi, Ph.D., and Bill Byrom, Ph.D., Signant Health | GLP-1 agonists are revolutionizing obesity treatment. Signant Health's ePRO solutions support over 30 trials, providing critical patient data and driving successful approvals. |
|
|
| Why Now Is The Right Time To Adopt eConsent | Article | By Kate Yawman, Advarra | As much as eConsent helps staff, participants are also likely to prefer it over traditional paper methods. Explore the benefits of eConsent and some strategic steps sites can take right now to adopt the process. |
|
|
|
| SMART On FHIR: Auto-Populate eCRFs On Study Day 1 | Article | By Cal Collins, OpenClinica | Get an overview of SMART on Fast Healthcare Interoperability (FHIR) for clinical trials, including workflow improvements, real-world data (RWD) integration, and reducing researcher burnout. |
|
|
| Connecting Patient-Level Clinical Data To RWD | White Paper | Medidata AI | Discover data linkage: a cutting-edge innovation that unlocks a new frontier of enhanced evidence generation by linking clinical trial data and real world data at the patient level. |
|
|
.png){kind=logo}
